Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
The S&P/TSX Composite Index dropped 90 points on Tuesday, August 9. Most sectors finished the day in the red, and those that did not were only able to deliver marginal gains. It is still a challenging environment for investors in the late-summer season. Today, I want to discuss what...
Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) PR Newswire CMS Issues New Specific ICD-10 Code K76.82 for HE LAVAL, QC , Aug. 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch ...
Bausch Health Companies missed expectations and cut its guidance. Xifaxan patent questioned, adding to uncertainties. Strong quant scores risk a negative revision. Bausch Health's ( BHC ) poorly timed spin-off of B+L (BCLO) and unfavorable Xifaxan patent order underm...
Bausch Health Companies Inc. (BHC) Q2 2022 Earnings Conference Call August 9, 2022 08:00 ET Company Participants Christina Cheng - Senior Vice President, Investor Relations Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Confer...
The following slide deck was published by Bausch Health Companies Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Bausch Health Companies Inc. 2022 Q2 - Results - Earnings Call Presentation
The shares of Bausch Health ( NYSE: BHC ) lost ~13% in the pre-market Tuesday after the Canadian pharma company fell short of Street forecast with its Q2 2022 financials and slashed the full year guidance as its quarterly revenue contracted amid divestitures and forex impa...
Bausch Health Companies press release ( NYSE: BHC ): Q2 GAAP EPS of -$0.40 misses by $0.30 . Adjusted net income attributable to Bausch Health (non-GAAP) 1 for the second quarter of 2022 was $201 million. Revenue of $1.97B (-6.2% Y/Y) misses by $70M ....
BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS PR Newswire Revenues of $1.967 billion Company to appeal anticipated court decision and vigorously defend XIFAXAN intellectual property Balance sheet continues to improve with early retirement of...
Bausch Health Companies ( NYSE: BHC ) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open. The consensus EPS Estimate is $0.91 (-6.2% Y/Y) and the consensus Revenue Estimate is $2.04B (-2.9% Y/Y). Over the last 1 year, BHC has beat...
A stock is oversold when it trades below its intrinsic or “true” market value. But the problem is that there are different ways of calculating a stock’s intrinsic value and may offer slightly different results. So, the level at which a stock may be considered oversold c...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
Stocks sold off Wednesday, weighed down by underwhelming reports from two mega-cap tech companies, leading to the S&P 500 and the NASDAQ Composite to post their worst session since 2022. The Dow Jones Industrials withered 504.22 points, or 1.3%, to 39,853.87. The much-broader index su...
A look at the top 10 most actives in Canada WildBrain Ltd. 5.875% Convertible Unsecured Subordinated Debentures (WILD.DB) rose 3.9% to $99.71 on volume of 19,212,000 shares Royal Bank of Canada (RY) fell 0.0% to $152.21 on volume of 13,856,076 shares Red Pine Exploration Inc. (RPX) fell 6...
LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources. The article contains unsubstantiated rumors, including that the Company is considering a bankruptcy o...